Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/19414673

J. Clin. Oncol. 2009 Jun 20 27 18 2983-90

Download in:

View as

General Info

PMID
19414673